N/A N=72 Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity
Morbid Obesity · Metabolic Syndrome X · Diabetes Mellitus
Primary: Excess Weight Loss From Baseline — 67.8; 64.2 percentage of EWL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=150 Gastric Procedures for Obesity
Morbid Obesity
Primary: Change in Body Weight — -21.4; -36.6; -7.0 kg
N/A N=197 Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity
Morbid Obesity
Primary: Excess Weight Loss From Pre-operation to 5 Years Post-operation — 68.4; 45.4 percent change
N/A N=25,038 Risk Factors Predicting Serious Complications With Laparoscopic Gastric Bypass Surgery
Postoperative Complications
Primary: Serious Complications — 630 Participants
N/A N=355 Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)
Morbid Obesity
Primary: Number of Participants With Postoperative Gastrointestinal Hemorrhage — 13; 39 participants
N/A N=24 Endoscopic Surgery for Bariatric Revision After Weight Loss Failure
Morbid Obesity · Weight Loss
Primary: Mean Weight Loss — 13.3 Pounds
N/A N=22 Diabetes and Gastric By- Pass
Type 2 Diabetes
Primary: Response in Glucose AUC at Baseline vs. Following Gastric Bypass Surgery — 61647.0; 59476.1 mg/dL*min
N/A N=34 Food Preference Following Bariatric Surgery
Obesity
Primary: Total Food Intake (Lunch Buffet) at 24 Months — 2540.1; 721 kJ
N/A N=20 Endoscopic Suturing for Primary Obesity Treatment
Obesity · Body Weight · Overweight
Primary: Number of Participants With Adverse Events — 5; 2; 0; 13 Participants
N/A N=293 Clinical and Economic Outcomes in Laparoscopic Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass Surgery
Morbid Obesity
Primary: Quality of Life (QOL) in First Postoperative Year According to EuroQol-5 Dimensions-5 Levels (EQ-5D-5L) — 3; 3 Score*months
N/A N=53 Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass
Gastroesophageal Reflux Disease · Morbid Obesity
Primary: Number of Participants Presenting Reflux Symptoms — 31; 8; 5 participants — p=<0.001
N/A N=39 Sonographic Evaluation of Visceral Fat After Bariatric Surgery
Morbid Obesity
Primary: Decrease in the Visceral Fat Layer Measured by Ultrasound a Day Before and a Year After Surgery. — 3.6; 7.1; 5.6 visceral fat reduction in centimeters
N/A N=41 The Effects of Glycemic Optimization Before Gastric Bypass Surgery
Type 2 Diabetes
Primary: Composite of Fasting Glucose, Glycosylated Haemoglobin c and Rates of Type 2 Diabetes Mellitus Remission. — 6; 6 Participants
N/A N=55 Effects of Gastric Bypass Surgery and Calcium Metabolism and the Skeleton
Obesity, Morbid · Gastric Bypass
Primary: Change in Intestinal Calcium Absorption — -25.8 % of ingested calcium that is absorbed
N/A N=30 Low-calorie Diet and Body Composition Prior to Roux-en-Y Gastric Bypass
Morbid Obesity · Liver Fat
Primary: Change in Intra-hepatocellular Lipid Content (IHCL) Following the Pre-operative Diet — 40.0; 67.4; 0.1 percentage of change in IHCL
N/A N=15 Assessment of Gastric Volume Reduction in Surgical Weight Loss Candidates
Obesity
Primary: Successful Gastric Plication Using Reduction Gastroplasty — 9; 6 participants
N/A N=15 Safety and Efficacy of Long Limb Roux-en Y Reconstruction
Diabetes Mellitus Type 2 in Nonobese · Gastric Cancer
Primary: Morbidity — 4 participants
N/A N=62 Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
Hypoglycemia · Obesity
Primary: Mean Serum Glucose Levels — 123.1; 157.5; 103.2; 138 mg/dl
N/A N=100 GAstric Bypass to Treat obEse Patients With steAdy hYpertension
Systemic Hypertension · Obesity
Primary: Number of Participants With a Reduction in the Number of Anti-hypertensive Drugs Used and Maintaining Blood Pressure Below 140x90mmHg — 41; 6 Participants
Phase 4 N=144 Surgical Conditions During Laparoscopic Bariatric Surgery
Morbid Obesity
Primary: Surgeon Satisfaction Scale — 2.7; 4.1; 3.1; 4.6 Scores on a scale
Phase 3 N=90 Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy
Pain · Postoperative Depression
Primary: Change in Pain Scores — 1.45; 1 score on a scale
N/A N=137 LAGB as a Treatment for Morbid Obesity in Adolescents
Morbid Obesity · Obstructive Sleep Apnea Syndrome · Metabolic Syndrome
Primary: Percentage of Excess Weight Change (EWL) — -35.5 percent change
N/A N=33 Taste Perception Pre and Post Bariatric Surgery
Morbid Obesity
Primary: Changes on Taste Detection Thresholds After Bariatric Surgery-induced Weight Loss (Roux-en-Y Gastric Bypass and Laparoscopic Adjustable Banding). — 7.5; 8.1; 6.5; 7.5…
N/A N=253 Laparoscopic Versus Transabdominal Ultrasound in Morbidly Obese Patients
Cholelithiasis · Ultrasonography · Laparoscopic Gastric Bypass
Primary: Cholelithiasis on Transabdominal Ultrasound Versus Laparoscopic Ultrasound. — 61; 60 participants — p=0.763
N/A N=48 An Analysis of Lipid and Glucose Metabolism Following Bariatric Surgery
Morbid Obesity
Primary: Triglycerides Post-prandial — 95; 71; 134 mmol/L
N/A N=50 Bariatric Surgery for Morbid Obesity
Obesity · Morbid Obesity
Primary: Size of Adipocytes — 73.4; 99.0; 103.0 µm
N/A N=57 Laparoscopic Adjustable Gastric Banding in Adolescents
Morbid Obesity
Primary: Total Weight Loss — 11.35 kilograms
N/A N=106 Hepatic Effects of Gastric Bypass Surgery
Liver Diseases
Primary: Aspartate Transaminase (AST) Change — -6.32 U/L — p=0.03
Phase 4 N=61 Preoperative Pain Control in Gastric Bypass Surgery Patients
Post-operative Pain
Primary: Post-operative Pain Medication Requirements — 13.76; 17.32; 40.89; 46.63 MME — p=0.10
N/A N=30 Ileal Interposition With Sleeve Gastrectomy for Control of Diabetes
Diabetes
Primary: Percentage of Participants Having Remission of Type 2 Diabetes — 76.66 Percentage of Participants